Preferred Name |
aclacinomycins |
|
Synonyms |
siwenmycin |
|
ID |
http://purl.bioontology.org/ontology/MESH/C011157 |
|
altLabel |
siwenmycin aclacinomycin T aclacinomycin Y aclacinomycin X aclacinomycin N aclacinomycin aclacinomycin B MA 144 S1 aclacinomycin S MA 144 N1 aclacinomycin Hydrochloride aclacinomycin M |
|
cui |
C0889093 C0050561 C0889092 C0919315 C0101253 C0889097 C0889096 C0889094 C0101254 C0065458 C0889095 C0065459 |
|
Has mapping qualifier | ||
HM |
D015250/Q000031 |
|
Inverse of RB |
64431-69-2 108147-58-6 67298-12-8 64431-68-1 66676-88-8 0 74564-62-8 P8EJD9HI5K 64474-88-0 60504-57-6 |
|
isa | ||
Mapped to | ||
MDA |
19760101 |
|
MeSH Frequency |
163 |
|
MMR |
20150817 |
|
notation |
C011157 |
|
PA |
D000903 D000276 |
|
PI |
ANTHRAQUINONES (76-78) NAPHTHACENES (76-88) GLYCOSIDES (76-78) |
|
prefLabel |
aclacinomycins |
|
RR |
64431-69-2 108147-58-6 67298-12-8 64431-68-1 66676-88-8 57596-79-9 (aclacinomycin B) 74564-62-8 P8EJD9HI5K 64474-88-0 60504-57-6 |
|
SC |
1 |
|
SRC |
Biochemistry 1979;18(18):4024 Biochem Biophys Res Commun 82(1):188;1978 Cancer Res 38:1782;1978 J Antibiotics 28(10):830;1975 Antibiot Chemother 23:76;1978 Cancer Treat Rep 63(5):931;1979 Gann 68(5):685;1977 Jpn J Antibiot 30 suppl:S-70;1977 J Antibiot (Tokyo) 32(1):48;1979 Cancer Treat Rep 63(5):875;1979 Lancet 2(8137):301;1979 J Antibiot 1979;32(5):472 Folia Microbiol 23:152;1978 J Antibiotics 31(9):919;1978 Recent Results Canc Res 63:241;1978 |
|
TERMUI |
T087252 T341386 T341389 T341390 T087254 T341391 T341388 T113200 T087253 T113202 T341387 T113201 T113199 |
|
TH |
NLM (1976) INN (19XX) FDA SRS (2015) |
|
tui |
T109 T195 |